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Abstract
Background: In a substantial proportion of depressed patients, stressful life events play a role in triggering the evolution of
the illness. Exposure to stress has effects on different levels in laboratory animals as well and for the rat it has been shown
that chronic mild stress (CMS) can cause antidepressant-reversible depressive-like effects. The adoption of the model to the
mouse seems to be problematic, depending on the strain used and behavioural endpoint defined. Our aim was to evaluate
the applicability of CMS to mice in order to induce behavioural alterations suggested to reflect depression-like symptoms.
Methodology/Principal Findings: A weekly CMS protocol was applied to male mice of different mouse strains (D2Ola, BL/6J
and BL/6N) and its impact on stress-sensitive behavioural measures (anhedonia-, anxiety- and depression-related parameters)
and body weight was assessed. Overnight illumination as commonly used stressor in CMS protocols was particularly
investigated in terms of its effect on general activity and subsequently derived saccharin intake. CMS application yielded
strain-dependent behavioural and physiological responses including ‘paradox’ anxiolytic-like effects. Overnight illumination
was found to be sufficient to mimic anhedonic-like behaviour in BL/6J mice when being applied as sole stressor.
Conclusions/Significance: The CMS procedure induced some behavioural changes that are compatible with the common
expectations, i.e. ‘anhedonic’ behaviour, but in parallel behavioural alterations were observed which would be described as
‘anomalous’ (e.g. decreased anxiety). The results suggest that a shift in the pattern of circadian activity has a particular high
impact on the anhedonic profile. Changes in activity in response to novelty seem to drive the ‘anomalous’ behavioural
alterations as well.
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Introduction
Animal models are important research tools in psychiatry and
should mimic some of the human conditions of interest. According
to DSM-IV [1], major depression is characterised by either
depressed mood or anhedonia, in combination with four
additional symptoms related to weight changes, sleep disturbances,
psychomotor agitation or retardation, fatigue, feelings of worth-
lessness or guilt, diminished cognitive functioning, or recurrent
thoughts of death. The presence of some of these symptoms can be
defined operationally (e.g., loss of appetite and weight, sleep
disturbances, cognitive and psychomotor changes), and thus can
be assessed in laboratory animals.
Stressful experiences have been reported to favour the develop-
ment of depression in humans [e.g. 2,3]. Therefore, in order to
provoke depressive-like behavioural changes, some animal models for
this phenotype are generated by exposing them to stressful situations
[4–8]. In rats, application of chronic mild stress (CMS) procedures
resulted in a variety of behavioural, neurochemical, neuroendocrine
and neuroimmune alterations resembling some of the dysfunctions
observed in human depression [9–16]. Therefore, the CMS model,
developed by Willner and colleagues [4], has attracted a lot of interest
due to its potential of combining several validity criteria requested for
an animal model of depression [16,17]. In terms of symptoms evoked
by CMS, the induction of anhedonia was the primary focus in this
model [4]. Anhedonia, a core symptom of depression, was modelled
by inducing a decrease in responsiveness to rewards reflected by a
reduced consumption and/or preference of sweetened solutions. In a
more recent review, Willner [17] summarises results of positive
reproduction of CMS-induced anhedonia as well as ‘anomalous’
findings. In this context the attributes ‘anomalous’ or ‘paradox’ refer
to findings that include CMS-induced anxiolysis and hyperlocomo-
tion and apparently are contrary to ‘classic’ comorbidities of
depression-related behaviour such as increased anxiety and reduced
locomotor activity [17,18]. Most studies were performed in rats but
the few that used mice generally point towards the applicability of a
non-standardised CMS procedure to induce anhedonic behaviour in
mice as well. One reason for the adoption of this approach to mice
was the introduction of genetic mouse models as tools in psychiatric
disorder research. Using mice with specific genetic modifications in
suspected vulnerability genes in combination with CMS as
environmental factor will allow scrutinising the role of both, the
candidate gene and stress in a genetically predisposed animal, as risk
factors for depression.
Studies published on the effects of CMS on mouse behaviour
agreed on the importance of the strain used and showed that some
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4326strains are responsive to the CMS procedure, a finding which
strongly depends on the respective endpoint defined [19–24]. The
co-occurrence of CMS-induced alterations in palatable liquid
consumption and other behavioural and physiological parameters,
suggested to reflect depressive-like behaviour, has rarely been
studied in mice. Pothion and colleagues [21] investigated three
different mouse strains in terms of sucrose consumption, body
weight changes, coat state, spontaneous alternations in the Y-maze
and spatial learning in the Morris water maze test. Only in one
strain (CBA/H) a decrease in sucrose consumption was found
along with changes in physiological or behavioural parameters.
Therefore, a CMS-induced reduction of sucrose consumption was
not predictive of the occurrence of any other parameter assessed in
the study. Applying a different chronic stress procedure in BL/6N
mice, comprising more severe stressors presented in a more
sequential than unpredictable manner, Strekalova and colleagues
[25] described an association of a stress-provoked decrease in
sucrose preference and behavioural measures that were restricted
to increased passivity in the forced swim test (FST) as well as
decreased novel object exploration. An increase in anxiety-related
behaviour and locomotor disturbances were found to be induced
by the stress procedure independent of the induction of
‘‘anhedonic’’ behaviour [25]. In other studies using the CMS
procedure, an increase in immobility in the FST [26–28],
decreased grooming [23], altered performance in cognitive tasks
[29] as well as changes in anxiety-like behaviour [20,24] were
observed. These behavioural measures were considered to reflect
additional depression-related symptoms [17]. Unfortunately con-
sumption of sweetened solutions was not assessed in all these
studies.
A CMS model with a decrease in intake and preference of
sweetened solutions as central readout presents specific advantag-
es. Contrary to operant behaviour it can be implemented without
cost-intensive apparatus, it is non-invasive (in contrast to e.g.
intracranial self-stimulation), and the progressive evolution of a
depression-related symptom as well as the time course of
antidepressant-induced resolution of the symptom can be traced
by repeated measurements. The latter is rather difficult for a
variety of test paradigms used to assess, for example, anxiety-like
behaviour. As stated by Anisman and Matheson [5], an
appropriate model of depression requires that multiple behaviour-
al tests be employed to approximate the range of symptoms that
characterise depressive illness. Therefore, the aim of our studies
was to further investigate the feasibility to establish a CMS model
which includes the measurement of intake and preference of a
sweetened liquid and addresses additional indicators of depressive-
like behaviour. We used a stress-procedure which included most of
the commonly used ‘‘mild’’ stressors [30] but was devoid of food or
water deprivation. Measurements were performed 2–3 times per
week with the aim to possibly gain information on a direct effect of
the precedent stressor on ‘‘hedonic’’ behaviour. CMS effects on
intake of a 0.2% saccharin solution and body weight gain were
assessed in different mouse strains as the vulnerability for stress-
induced changes is supposed to be genetically determined. In
selected mouse strains, we investigated the influence of CMS on
anxiety-related behaviour and on passive behaviour in the FST.
The fluctuations in saccharin intake observed in the first
experiments showed a tendency of association to the precedent
stressor which according to our interpretation had some impact on
nocturnal activity of the mice. Therefore, an independent
experiment aimed at detecting the influence of overnight
illumination as particular stressor on subsequent saccharin intake
and activity in parallel.
Materials and Methods
Animals and housing conditions
Male mice from seven strains (Balb/cOla, C57BL/6JOla,
C57BL/6N, DBA/2Ola, DBA/2JIco, FVB/N, NMRI) - referred
to as Balb/c, BL/6J, BL/6N, D2Ola, D2JIco, FVB and NMRI
respectively - were purchased from Harlan-Winkelmann GmbH
(Borchen, Germany; Balb/c, BL/6J, D2Ola, FVB and NMRI)
and Charles River GmbH (Sulzfeld, Germany; BL/6N and
D2JIco). Upon arrival, the animals were singly housed in
Macrolon Type II cages under standard laboratory conditions
(temperature 2161uC, rel. humidity 40–60%, 12h:12h light/dark
cycle, lights on 6 A.M.), had free access to food and water and
were allowed to habituate to the novel environment for at least
2 weeks. Afterwards, the basal consummatory behaviour for water
and either saccharin or sucrose (intake and preference) was
determined. Based on these parameters and on body weight, mice
were matched and assigned to stress and control groups. Animal
experiments were performed in accordance with the NIH Guide
for the Care and Use of Mammals in Neuroscience and
Behavioural Research and the Guide for the Care and Use of
Laboratory Animals of the Government of Bavaria, Germany.
CMS Paradigm
The CMS procedure followed a fixed weekly schedule of
commonly used mild stressors such as repeated cold stress (4uC),
space reduction in the homecage, changed cages within CMS
group, cage tilt, empty cage, intermittent air puff, wet bedding,
white noise, overnight illumination and social interaction with
other animals of the CMS group. The particular context (stressor
applied during preceding dark phase) of the 2 hrs liquid
consumption measurement intervals involved overnight illumina-
tion (Sunday–Monday), wet cage and cage tilt (Tuesday–
Wednesday and Thursday–Friday, long-term CMS in BL6/J
and D2Ola mice) and changed cages (Wednesday–Thursday,
shorter CMS in BL6/J, BL6/N and the other strains), respectively.
For details see Table 1.
Behavioural Tests
Consummatory Behaviour. Extensive preliminary tests for
preference of cage side, saccharin preference over water, saccharin
concentration and one- versus two-bottle paradigm conducted
before the CMS period in the long-term CMS paradigm resulted
in the following measurement protocol. Liquid intake was
determined 3 times a week (Monday, Wednesday, Friday) in a
two-bottle paradigm by weighing the bottles before and after the
first 2 hours of the dark phase (=measurement interval of liquid
consumption) on the basis of D’Aquila’s studies [31]. Sweet
solutions were offered on the preferred right cage side, as a shifting
from the preferred solution at the preferred cage side to water at
the other side might more closely model anhedonic behaviour.
With the exception of the experiment in BL/6N mice, a 0.2%
saccharin solution was presented as palatable liquid. Using BL/6N
mice and applying a different stress procedure Strekalova et al.
[25] reported a decrease in sucrose preference coupled with other
behavioural alterations. In order to test whether our CMS
procedure induces a profile in BL/6N mice comparable to the
reported one we stayed with the presentation of sucrose and
changed the stress protocol only.
In the other experiments saccharin was chosen to avoid a caloric
impact of the sweetened liquid consumption on the CMS effects.
Since saccharin presentation 3 times a week might have worn
down the hedonic value of saccharin also in control mice, in the
CMS-Anhedonia-Activity
PLoS ONE | www.plosone.org 2 January 2009 | Volume 4 | Issue 1 | e4326shorter experiments sweet solutions were presented only twice a
week on Monday and Thursday.
Dark/Light Box (DaLi). Anxiety-related behaviour was
assessed in a DaLi (dark compartment 15620625 cm, light
compartment 30620625 cm, connected by a 4 cm long tunnel).
The light compartment was illuminated with 700 lx (for D2Ola
and BL/6J mice) and 50 lx (for BL/6N animals) cold light,
whereas in the dark compartment the illumination level was 5 lx.
Animals were placed in the dark compartment and the time spent
in, the latency to first entry (all four paws) and the number of
entries into each compartment was recorded for 5 min using the
ANY-maze software (Stoelting Co., Wood Dale, IL).
Forced Swim Test (FST). Each animal was placed into a
beaker (diameter 12 cm, height 24 cm) filled with water
(temperature 25226uC) to a height of 12 cm for a test period of
5 min. The parameters floating (immobility with only small
movements to keep balance), swimming and struggling (vigorous
attempts to escape) were scored throughout the 5 min test period
by a trained observer blind to the treatment and recorded using
the ANY-maze software.
Modified Hole Board Test (mHb). The mHb test (for
details see [32]) was performed at 6 P.M. at 60 lx (long-term CMS)
and 30 lx (BL/6N) respectively. The apparatus consisted of a dark
grey PVC box (100650 cm, 50 cm height) containing a board
(7062060.5 cm) in the centre which was equipped with 12
cylinders (‘‘holes’’, 2 cm height63 cm diameter). Behavioural
parameters such as time spent on board (with all four paws),
rearing (standing in an upright position on the hindpaws) and
locomotor activity (total distance travelled) were recorded during a
5 min session using the ANY-maze software.
Experimental Design
Assessment of CMS effects on consummatory
behaviour. a) Long-term CMS in BL/6J and D2Ola mice:
Animals (n=24 per strain) underwent preliminary tests to develop
the liquid intake measurement protocol. Subsequently, at an age of
36 weeks, the CMS regimen was applied for 13 weeks (for each
strain control and stress group n=12). During the CMS period the
saccharin consumption was measured 3 times a week (Monday,
Wednesday and Friday) for 10 weeks.
b) Short-term CMS in other mouse strains: An independent
batch of BL/6J animals (aged 12 weeks at the beginning of CMS
application, n=10/group) was tested to assess reproducibility of
CMS-effects on consummatory behaviour. BL/6N mice (aged
17 weeks at the beginning of the stress period, 9 control and 20
CMS animals) were offered a 2% sucrose solution for 4 weeks of
CMS.
Consummatory behaviour was accordingly assessed also in
additional mouse strains during 3–4 weeks of CMS. The animals
were aged 12 weeks (Balb/c, n=10/group), 7 weeks (D2JIco,
n=24/group) and 21 weeks (FVB and NMRI, n=8/group),
respectively, at the beginning of the stress period.
Assessment of CMS effects on anxiety- and depression-
related behaviour. a) Long-term CMS in BL/6J and D2Ola
mice: The long-term (13 weeks) stressed BL/6J and D2Ola mice
were tested in the DaLi after 11 weeks and the FST after 12 weeks
of CMS exposure. The testing times were 6 P.M. and 8 A.M.,
respectively. The week after, mice were tested in the mHb (6 P.M.,
60 lx).
b) Short-term CMS in BL/6J and BL/6N mice: The short-term
(4 weeks) stressed BL/6J mice were tested for anxiety-related
behaviour in the DaLi after 2 weeks and for depression-related
behaviour in the FST after 4 weeks of CMS. The FST was
conducted from 9 A.M. to 12 P.M. under standard laboratory
conditions. Before being tested for CMS effects on sucrose
consumption as described above, the BL/6N mice were
characterised in their basal (=non-stressed) behaviour in several
paradigms (DaLi, elevated plus maze, open field, resident-intruder
test), then following the CMS procedure for 4 weeks were re-tested
in the above mentioned paradigms (plus FST) and subjected to
additional 3 weeks of CMS. Stress effects on behaviour were
finally assessed in the mHb. All behavioural tests were conducted
during the first 2 hours of the dark phase (corresponding to the
consumption measurement interval) either at reduced illumination
(mHb: 30 lx) or under red light conditions (all other tests).
Effects of overnight illumination as sole stressor in BL/6J
mice. For 4 weeks, BL/6J mice (40 stressed and 36 control
animals aged 7 weeks at the beginning of the stress period) were
exposed to overnight illumination (light stress, LS) twice a week
(Sunday and Wednesday) and the saccharin consumption and
homecage activity was measured during the following dark period
(Monday/Tuesday and Thursday/Friday, respectively). No
further stressors were applied. To assess their general activity
pattern, mice were monitored in their homecages in side-view
using small CCD cameras and the ANY-maze software.
Parameters such as locomotor activity, rearing and climbing
behaviour were determined. Data were analysed for the 2 hrs
consumption measurement interval as used in the CMS
experiments and for the subsequent 22 hours to yield a 24 hrs
consumption/activity profile.
Table 1. Weekly CMS schedule
LIGHT PHASE DARK PHASE
First half Second half First 2 hrs Remaining 10 hrs
Mon Repeated Cold Stress (2630 min) Cold Stress (30 min) 2 hrs liquid intake measurement* Homecage Space Reduction
Tue Changed Room Air Puff (363 intermittent) Wet Cage Wet Cage
Wed Wet Cage Social Interaction Foreign Cage Foreign Cage
Thu Foreign Cage Social Interaction 2 hrs liquid intake measurement* Cage Tilt
Fri Empty Cage Changed Room White Noise&Strobe White Noise&Strobe
Sat White Noise Pause/Changed Room Pause/Changed Room Pause/Changed Room
Sun Pause/Changed Room Pause/Changed Room Overnight Illumination Overnight Illumination
*Exemplified for short-term CMS experiments. During long-term CMS liquid intake was assessed on Mon, Wed and Fri in the same interval.
doi:10.1371/journal.pone.0004326.t001
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Data were analysed using STATISTICA Software 6.0 (Statsoft
Inc., Tulsa, US). A two-sided Student’s t-test was applied for
comparison of two experimental groups. For time series analysis
(consummatory behaviour and locomotor activity) repeated
measures ANOVA with Greenhouse-Geisser correction for non-
sphericity was used. For traceability reasons uncorrected degrees
of freedom plus the respective correction factor e and corrected F
values are shown. When repeated measures ANOVA revealed a
significant interaction effect of the factors time and group, data
were further analysed with pairwise comparisons for each time
point (Student’s t-test). The inter-strain comparison of saccharin
intake (see supplementary material) was analysed using one-way
ANOVA followed by Tukey post-hoc testing. For the analysis of
body weight gain averages were calculated for the CMS period
and compared using a two-sided Student’s t-test. Effects were
considered significant when p,0.05.
Results
CMS effects on consummatory behaviour in different
mouse strains
For saccharin intake of long-term CMS exposed D2Ola mice
repeated measurement ANOVA yielded no significant effect for
the factor ‘‘group’’ (=CMS). After beginning of the CMS
period, at the times marked in Figure 1A, differences in
saccharin consumption in the experimental groups could be
detected (interaction group6time: F31,682=9.29; p,0.01;
e=0.359), albeit stating in some measurements an elevated
intake in CMS mice compared to the control group. CMS had
no effect (factor group) on the preference for saccharin in D2Ola
mice (Figure 1A), no significant interaction resulted from the
factors group and time.
In BL/6J mice, statistical analysis revealed a reduced saccharin
intake (factor group: F1,22=12.30; p,0.01). This difference also
appeared in the interaction of the factors group6time
(F30,660=14.27; p,0.01; e=0.366), whose details are illustrated
in Figure 1A. CMS led to a decreased saccharin preference (factor
group: F1,22=4.92; p,0.05; interaction group6time
F30,660=2.57; p,0.01; e=0.298) of BL/6J animals in the long-
term CMS paradigm (see Figure 1A). After four weeks CMS
exposure, these findings could be replicated for an independent
batch of BL6/J mice (data not shown) regarding their saccharin
intake (factor group: F1,18=24.98; p,0.01; interaction group6
time: F5,90=4.33; p,0.01; e=0.584) but not in respect of their
saccharin preference.
Further, as illustrated in Figure S1, the CMS regimen affected
saccharin intake of Balb/c mice (factor group: F1,18=6.03;
p,0.05; interaction group6time: n.s.), FVB animals (factor group:
F1,14=14.09; p,0.01; interaction group6time: F8,112=5.63;
p,0.01; e=0.536), NMRI mice (factor group: F1,14=6.75;
p,0.05; interaction group6time: n.s.) and D2JIco mice (factor
group: F1,45=12.90; p,0.01; interaction group6time: n.s.). Inter-
strain comparison for basal saccharin consumption and percental
change induced by CMS is provided in Table S1.
In BL/6N mice, repeated measurements ANOVA yielded
no CMS effect on sucrose intake in terms of factor group but an
interaction effect of factors group6time (F7,245=5.89; p,0.01;
e=0.618). Sucrose preference was significantly decreased by
CMS (factor group: F1,35=13.48; p,0.01; interaction factors
group6time: F7,245=3.32; p,0.01; e=0.629). The sucrose
consumption of BL/6N mice is illustrated in Figure 1B.
CMS effects on anxiety- and depression-related
behaviour and body weight gain
BL/6J mice were selected to be further investigated as this
mouse strain is commonly involved in the generation of transgenic
mice. We were interested in the D2Ola mice as we observed in
previous studies that D2Ola compared to BL/6J responded with a
reduced inhibitory HPA axis feedback to a single stress exposure
[33]. BL/6N mice were integrated in our studies as Strekalova et
al. [25] showed an association of anhedonic and depressive-like
behaviour for a subgroup of this mouse strain after chronic stress.
Dark/Light Box (DaLi). Long-term CMS application
caused D2Ola mice to spend significantly more time in the lit
compartment compared to controls (t21=4.55; p,0.01), whereas
stressed BL/6J mice of the same experiment did not show an
altered behaviour in the DaLi paradigm (Figure 2A). The latter
finding was in line with results obtained using the same strain in
the DaLi test after 2 weeks of CMS (Figure 2B). In BL/6N mice,
the time spent in the lit compartment was not affected by 4 weeks
of CMS pre-experience (Figure 2C).
Modified Hole Board (mHb). Behaviour of the different
strains in the mHb is displayed in Figure 3. Long-term stressed
D2Ola animals spent more time on the board (t20=2.78; p,0.05),
while rearing behaviour and locomotor activity tended to result in
a slight increase due to CMS. BL/6J animals did not show any
behavioural changes induced by CMS in the mHb test. However,
mHb testing revealed strong effects of 7 weeks of CMS on
behaviour of BL6/N mice: Time spent on board, number of
rearings and locomotor activity were significantly increased in
stressed animals (time board: t16=2.91; p,0.05, rearing:
t16=3.23; p,0.01, locomotion: factor group F1,16=14.82;
p,0.01; interaction group6time: F9,144=1.97; p,0.05).
Forced Swim Test (FST). In none of the investigated mouse
strains an increased immobility in the FST due to CMS could be
observed (p.0.05) (Figure 4).
Body weight gain. As illustrated in Figure 5A, CMS reduced
body weight gain in D2Ola and BL/6J mice during the 13 weeks
CMS schedule (t21=2.22; p,0.05 and t22=4.00; p,0.01,
respectively). This result could be confirmed for mice of the latter
strain in the shorter CMS experiment (t17=2.93; p,0.01), whereas
CMS had no effect on body weight gain in BL/6N animals
(Figure 5B).
Effects of overnight illumination as sole stressor in BL/6J
mice
Consummatory behaviour. Overnight illumination as sole
stressor was able to considerably decrease saccharin intake of BL/6J
animals during the 2 hrs measurement interval (factor group:
F1,74=185.96; p,0.01; interaction group6time: F7,518=6.22;
p,0.01; e=0.715), an effect that almost retained significance
throughout the 24 hrs measurement interval (factor group:
F1,74=3.60; p=0.06; interaction group6time: n.s.), for details see
Figure 6A.
Homecage activity. BL/6J animals exposed to overnight
illumination as sole stressor showed reduced homecage activity in
the 24 hrs interval (factor group: F1,62=6.73; p,0.05),
whereupon localisation of differences revealed a distinctly
decreased activity during the first 3 hours of the dark phase
(interaction group6time: F22,1364=12.25; p,0.01; e=0.149), i.e.
comprising the time span during which both 2 hrs saccharin
measurement took place and control animals peaked in homecage
activity (for details see Figure 6B). Overnight illumination delayed
(and decreased) peak activity in the presence of the saccharin
solution in LS animals by around 2–3 hours. Two-way ANOVA
of homecage activity during dark and light phase yielded an
CMS-Anhedonia-Activity
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p,0.01), whose details are shown in Figure 6B. Here, overnight
illumination could be shown to reduce homecage activity during
the dark phase (p,0.01) while light phase activity remained
unchanged. Correlation of homecage activity of both control and
CMS animals during the 2 hrs consumption measurement
interval with 2 hrs saccharin intake revealed Pearson’s r=0.64
(p,0.01), see Figure 6B.
Figure 1. CMS effects on palatable liquid consumption per 2 hrs in D2Ola, BL/6J and BL/6N mice. (A) Effects of CMS on saccharin intake
and preference over a period of 10 weeks in D2Ola and BL/6J mice (measurement 3x/week). (B) CMS effects on sucrose intake and preference over a
period of 4 weeks in BL/6N mice (measurement 2x/week). Saccharin concentration: 0.2%, sucrose concentration 2%. White circles: control group,
black circles: CMS group. First 4 data points of each graph represent basal consumption. Data represent mean6SEM, n=9–20/group. * p,0.05,
** p,0.01 pairwise between-group comparisons (Student’s t-test).
doi:10.1371/journal.pone.0004326.g001
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behavioural changes reflected by an increase in time spent in the lit compartment (700 lx) compared to the control group. In BL/6J mice with similar
CMS experience no changes were observed. (B) BL/6J mice with CMS experience of 2 weeks were also unaffected in terms of time spent in the lit
compartment (700 lx). (C) BL/6N mice with CMS experience of 4 weeks did not differ from control mice in the parameter time lit, when tested at a
moderate illumination level of 50 lx in the lit compartment. Data represent mean + SEM, n=9–20/group. White bars: control group, black bars: CMS
group. ** p,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0004326.g002
Figure 3. CMS effects on behaviour in the mHb. In D2Ola mice 13 weeks of CMS led to an increase in time spent on the board, whereas BL/6J
animals of the same experiment did not show altered behaviour (time board, number rearings and distance travelled). Mice of the BL/6N strain
(7 weeks of CMS experience) showed significant increases in the parameters time board, number of rearings and an increased locomotor activity.
Illumination conditions: 60 lx (D2Ola, BL/6J) and 30 lx (BL/6N), respectively. Data represent mean6SEM, n=9–12/group. White circles and bars:
control group, black circles and bars: CMS group. * p,0.05, ** p,0.01 (Student’s t-test).
doi:10.1371/journal.pone.0004326.g003
CMS-Anhedonia-Activity
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The data presented in this study were derived during the
development of a CMS protocol focussed on consumption of sweet
solutions as central readout measure for hedonic/motivational
behaviour in mice. We used a stress-procedure which included
most of the commonly used ‘‘mild’’ stressors [16,17,30] but was
devoid of food or water deprivation. Five out of seven mouse
strains investigated responded with a decrease in the consumption
of the sweetened solution compared to the respective control
Figure 4. CMS effects on immobility in the FST. (A) 12 weeks of exposure to CMS had no effect on immobility time of D2Ola and BL/6J mice in
the FST. (B) 4 weeks of CMS exposure had no effect on immobility time of BL/6J mice. (C) After 4 weeks of CMS exposure, BL/6N mice were subjected
to the FST at the end of week 5. No changes in immobility time compared to the control group could be observed. Time of test: 8 A.M. (A,B) and 6
P.M. (C), respectively. Data represent mean + SEM, n=9–20/group. White bars: control group, black bars: CMS group.
doi:10.1371/journal.pone.0004326.g004
Figure 5. CMS effects on body weight. (A) The illustrated time courses of body weights are characterised by a flattened mean slope in CMS
animals compared to controls, thus revealing a reduced body weight gain due to CMS in both D2Ola and BL/6J mice of the long-term CMS
experiment. (B) In the shorter CMS experiments a similar reduction of body weight gain due to CMS could be observed in younger BL/6J but not in
BL/6N animals. Data represent mean6SEM, n=9–20/group. White circles: control group, black circles: CMS group.
doi:10.1371/journal.pone.0004326.g005
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of saccharin intake during the first 2 hrs interval while there was no effect on overall 24 hrs saccharin intake after LS. The dashed horizontal lines at
y=0,72 mL and y=4,80 mL, respectively, represent basal water intake when only water is available in a two-bottle paradigm during the
corresponding measurement interval. (B) Profiling of homecage activity for a total of 24 hrs (t0=beginning of the dark phase) revealed a distinct
decrease during the first hours of the dark phase (which comprised the 2 hrs saccharin measurement interval, hatched area) that was positively
correlated with the respective 2 hrs saccharin intake (Pearson’s r=0.64, p,0.01, n=76, i.e. 40 LS and 36 control animals). Data represent mean6SEM,
n=36–40/group. White circles and bars: control group, grey circles and bars: light stress group. * p,0.05, ** p,0.01 pairwise between-group
comparisons (Student’s t-test).
doi:10.1371/journal.pone.0004326.g006
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protocols has been able to yield an anhedonic phenotype in
rodents regardless of particular content or timetabling of
microstressors in the respective CMS schedule. Strain-dependent
effects of CMS on consumption of palatable solutions of mice have
been reported earlier [20,21,24].
These general findings could be confirmed in our study for
stressed BL/6J, D2Ola, D2JIco, FVB and BL/6N mice despite
differences in the designs of the experiments. However, the effects
of CMS appeared not to be enduring, since the saccharin intake of
the respective control group decreased to the level of stressed
animals after 4–6 weeks in the long-term CMS experiment.
Trying to re-establish their working CMS protocol after moving to
a new laboratory, Willner and colleagues reported similar
problems of an initially obtained anhedonic CMS effect in rats
that vanished after several weeks of stress application [16]. The
discrepancy to previous studies was explained by a diurnal
variation of CMS effects that were found to be more robust when
the sucrose test was performed during the dark period [31]. In our
study in mice, we followed the suggestion of measuring the intake
behaviour during the first hours of the dark period, therefore we
should have picked the most sensitive time period for measuring a
CMS effect on saccharin intake. In a study of Pothion and
colleagues [21] the difference between control and CMS groups of
mice in a 24 hrs sucrose test was also only observed for the first
4 weeks after onset of stress. We observed strong fluctuations in
the consummatory data in our experiments. These might be a
consequence of (1) the short measurement interval and the
consequential low intake during that time, (2) the assessment of
consummatory behaviour more than once a week and (3) a
possibly disturbing effect on the intake of control animals since
CMS mice most of the time were kept and stressed in the same
room [17].
One aim of the study was to identify potential differences on the
impact of specific stressors contained in the CMS procedure on
saccharin consumption and therefore, the protocol followed a
fixed weekly schedule rather than being designed entirely in an
unpredictable way. The preceding stressor with the largest effect
on saccharin intake in the experiments was the wet cage. Our
interpretation was that under this condition it was hard for the
animals to rest. Indeed, keeping rats in a wet cage was used to
establish an animal model of fatigue [34]. Thus, we followed the
idea of a potential impact of mild disturbance of activity/sleep
rhythm on saccharin consumption. Overnight illumination was
applied as the sole stressor and measuring the subsequent
saccharin intake was paralleled by recording homecage activity.
As shown in Figure 6A, the volume of saccharin consumption
during the first 2 hours at the beginning of the dark period of
stressed animals dropped to a level similar to basal water
consumption. In parallel, a reduction of activity was observed
that was most prominent during the time when saccharin was
presented. This suggests that the reduced saccharin intake was not
only due to a shift of general consummatory behaviour but
combined with a parallel shift and reduction in activity as observed
during the same time interval. There was a moderate positive
correlation of activity and intake during the time interval of
saccharin presentation for LS as well as control animals.
Therefore, the levels of activity and of saccharin intake are closely
interwoven and the potential influence of a stressor preceding the
saccharin measurement on activity changes should be considered.
In the rat version of the CMS model, changes in diurnal
rhythms [35] and sleep architecture [36,37] were reported.
Further, D’Aquila et al. [31] showed the diurnal variation of
CMS-induced anhedonic behaviour with its presence mainly
during the active phase (dark period) of the animals. Papp and
colleagues [38] concluded that the procedure causes a generalised
disorganisation of internal rhythms which are postulated to play an
important role in the pathophysiology of depression [39]. In mice,
strain-dependent differences in locomotor activity rhythm and its
changes due to daylight reversal [40], as well as a relation of sleep
changes due to mild stressors - like environmental novelty - with
trait anxiety [41] have been described.
Taken together, in addition to strain-dependent intake of
sweetened liquids [21,42,43] and stress effects on the reward
system [42,44], the sensitivity to changes in activity/sleep due to
the CMS procedure contributes to the final decrease in
consumption behaviour. This could be of specific relevance for
those studies that apply mild stressors and determine intake or
preference of sweetened solutions following different stressors [21].
A consequence could be a higher variation in the anhedonic
profile as observed in our study.
Besides the measurement of saccharin intake our second focus
was to address additional indicators of anxiety- and depressive-like
behaviour. Therefore, animals of three strains of mice were
additionally characterised regarding CMS effects on anxiety-
related behaviour. Furthermore, the animals were investigated in
the FST, a test often used to evaluate antidepressant-like
properties of substances [45]. First, BL/6J and D2Ola mice were
tested in above mentioned paradigms after CMS experience of
more than 10 weeks. Second, a different batch of BL/6J mice was
investigated after 2 weeks of CMS experience when the decrease
in saccharin intake became apparent. Third, experiments with
CMS-experienced BL/6N mice also addressed the influence of
illumination during behavioural testing [18]. Testing BL/6J and
D2Ola mice after long-term CMS experience revealed that BL/6J
mice remained unaffected by CMS, whereas D2Ola mice of the
CMS group showed a decrease in anxiety-related behaviour. In
the second group of BL/6J mice, after 2 weeks of CMS, again no
difference in anxiety-like behaviour was seen compared to the
control group. The anxiolytic-like effect of CMS in D2Ola mice is
commonly appraised ‘anomalous’, yet has also been found in other
chronic stress paradigms involving rats, other mouse strains and
different anxiety tests [23,46–52]. Generally, these findings are
interpreted as either being due to blunted emotionality [52] or
caused by methodological differences [48] of CMS procedures that
yield a ‘classic’ anxiogenic stress response. Nevertheless, the
resilience of BL/6J mice against disturbing CMS effects on
anxiety-related behaviour as shown by Mineur et al. [24] could be
confirmed in our study.
According to Strekalova et al. [18] bright and even moderate
illumination conditions (.5 lx) can confound anxiety- and
depression-related behavioural readout in chronically stressed
BL/6N mice in common test paradigms by eliciting hyperlocomo-
tion. Furthermore, chronic stress in general is supposed to exert
stimulating effects on locomotor activity [53] that might mask
other stress effects in anxiety- as well as in depression-related test
paradigms [18]. For this reason, in our study involving BL/6N
mice, illumination levels of the test apparatus were attenuated and
testing was performed at the beginning of the dark phase. Under
these conditions, no CMS-induced changes were observed in the
DaLi. In the mHb test a CMS-induced hyperlocomotion and
increased vertical exploration was paralleled by an increased time
spent on the board, thus fitting into the picture drawn by
Strekalova et al [18]. Since hyperlocomotion still appeared under
red light conditions in the open field test in BL/6N mice (data not
shown), our CMS protocol seems to exert additional effects on
reactivity to a test situation that lie beyond an increased sensitivity
to even moderate illumination conditions. Possibly in line with this
CMS-Anhedonia-Activity
PLoS ONE | www.plosone.org 9 January 2009 | Volume 4 | Issue 1 | e4326concept are the results of all conducted FSTs in our study where
no significant CMS-induced change in immobility was observed.
According to the outlined concept, an increased immobility might
have been concealed by CMS-induced hyperarousal, rather
independent of test time and illumination.
Taken together, our findings on anxiety- and depression-related
behaviour point towards a higher reactivity to a novel situation in
response to CMS. This might imply the need to put the
‘anomalous’ behavioural profile in response to our CMS protocol
in perspective - although this conclusion is highly speculative in
respect to our limited data. Taking into account the above
described inefficiency of CMS to alter anxiety-related behaviour in
BL/6J mice, the presented data suggest that the occurrence of
anhedonic behaviour and changes in behaviour assessed in tests
for anxiety- or depression-related behaviour were uncoupled from
each other.
Strain effects of CMS are further diversified by different
responses of body weight gain. Whereas BL/6J and D2Ola mice
showed a reduced body weight gain due to CMS, BL/6N
remained entirely uninfluenced by CMS in this parameter.
Apparently stressor intensity was high enough to yield an
attenuation of body weight gain in D2Ola and BL/6J mice, while
BL/6N mice seem to require stronger stressor application to show
the same effect [18,25]. Particularly in the face of contradictory
findings reported in other CMS studies [20,21] we consider the
observed changes in body weight gain as a verification of CMS
effectiveness in general rather than associating them with the
phenomenology of major depression.
On the basis of the results obtained so far, our next steps in the
direction of a CMS model in mice will include some modifications
of the CMS procedure and the experimental design. Assessment of
consummatory behaviour will be accompanied by detailed
determination of homecage activity during the saccharin tests,
and finally, the effects of antidepressant treatment on the diverse
behavioural endpoints included in the present study will decide
upon the applicability of our CMS model in general and
additionally might reveal a possible relation of ‘anomalous’
behavioural changes to symptoms observed in human depression.
Supporting Information
Figure S1 Effects of short-term CMS on saccharin consumption
per 2 hrs in other mouse strains Effects of CMS on saccharin
intake over a period of 3-4 weeks in Balb/c, D2JIco, FVB and
NMRI mice (measurement 2x/week). White circles: control group,
black circles: CMS group. First 4 data points of each graph
represent basal consumption. Data represent mean6SEM, n=8-
24/group. * p,0.05, ** p,0.01 pairwise between-group compar-
isons (Student’s t-test).
Found at: doi:10.1371/journal.pone.0004326.s001 (0.45 MB TIF)
Table S1 Inter-strain comparison of saccharin intake before and
after CMS application in stressed animals. Averaged saccharin
intake during 2 weeks under basal conditions, the same parameter
corrected for body weight and averaged intake during the first 3-
4 weeks of CMS (as percentage of basal intake). a-f indicate
significant differences to Balb/c, BL/6J, D2JIco, D2Ola, FVB and
NMRI mice, respectively (Tukey test). Data represent mean6-
SEM of CMS animals only, n=8-24/group.
Found at: doi:10.1371/journal.pone.0004326.s002 (0.01 MB
RTF)
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